SCOTUS Declines to Hear Argument Over FCA “Objective Falsehood”
March 30, 2021
The U.S. Supreme Court has decline to hear argument over “objective falsehood” under the False Claims Act (FCA). This has been a hot button issue
Blog
Sacklers Testify Before Congress
December 28, 2020
Two members of the Sackler family testified in front of Congress this month. David and Kathe Sackler both held executive positions and were active members
Purdue Hired McKinsey Consulting Firm to ‘Turbocharge’ Opioid Sales
November 30, 2020
As U.S. prosecutors go through document in an attempt to hold drug companies, distributors, and pharmacies accountable to the part they played in the U.S. opioid
Effect of COVID-19 Pandemic on Opioid Crisis and Litigation
August 30, 2020
As the COVID-19 pandemic continues to plague America, worsening the opioid crisis that has plagued the nation for decades, litigation to recoup the cost of
Lack of Pharmacy Oversight Contributed to Opioid Crisis
July 30, 2020
The opioid crisis has highlighted problems with Pennsylvania’s prescription drug monitoring system. Over the past few years the Pennsylvania Department of Health has worked on
Superior Court Upholds $70M Risperdal Verdict
November 29, 2019
A Pennsylvania Superior Court has rejected Johnson & Johnson’s appeal of a 2016 $70 million verdict awarded to a 20 year-old Tennessee man, Andrew Yount
Thousands of Risperdal Cases Previously Time-Barred, Reopened
November 21, 2019
In a 6 to 1 decision, the Pennsylvania Supreme Court opened the door for thousands of pending Risperdal injury cases to proceed to trial. The
$8 Billion Verdict: Jury decides J&J should pay in Risperdal case
October 9, 2019
October 9, 2019: Late yesterday a Philadelphia jury rendered an $8 billion punitive damages verdict against pharmaceutical company Johnson & Johnson for illegally marketing the antipsychotic drug Risperdal, putting
Will Fines Change Corporate Culture That Caused Opioid Crisis?
September 3, 2019
An Oklahoma judge order Johnson & Johnson (J&J) subsidiary Janssen Pharmaceuticals to pay a $572 million fine to the state for fueling the opioid crisis.
Opioid Drugmakers May Be Liable Under Consumer Protection Laws
July 29, 2019
Philadelphia District Attorney Larry Krasner has been given approval by a state judge to move forward with with action against drugmakers and distributors for illegal marketing and
Temple Law Honors Sheller with Doctor of Humane Letters
April 26, 2019
Attorney Stephen Sheller, founder of Sheller PC, was honored with a doctor of humane letters degree at Temple University’s Beasley School of Law 2019 Commencement
April 23rd, Book Signing: Big Pharma Big Greed
April 22, 2019
When: Tuesday, April 23, 2019 Time: 5:30 PM Location: Shakespeare & Co., 1632 Walnut Street, Philadelphia, PA 19103 Description: Big Pharma, Big Greed: The
